把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-06-30 |
| 3/3 |
| $1.31B |
| $249.1M |
| $633.5M |
| 63.4% |
| 24.3% |
| 98 |
| 尚无授权文本 |
| MDXG MIMEDX GROUP, INC. | 2026-06-30 | 3/3 | $64.36M | -$14.84M | — | 69.0% | -28.7% | 119 | 尚无授权文本 |
| FDX FEDEX CORP | 2026-05-31 | 3/3 | $94.72B | $4.43B | — | — | 5.8% | 107 | 尚无授权文本 |
| DXLG DESTINATION XL GROUP, INC. | 2026-05-02 | 3/3 | $103.34M | -$5.94M | -$12.65M | 44.3% | -5.7% | 99 | 尚无授权文本 |
| AIDX 20/20 Biolabs, Inc. | 2026-03-31 | 3/3 | $353,375 | -$2.17M | — | 17.8% | -408.4% | 8 | 尚无授权文本 |
| ALDX Aldeyra Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$3.45M | — | — | — | 103 | 尚无授权文本 |
| ARDX ARDELYX, INC. | 2026-03-31 | 3/3 | $94.47M | -$37.61M | -$32.31M | 94.9% | -34.7% | 97 | 尚无授权文本 |
| BDX BECTON DICKINSON & CO | 2026-03-31 | 3/3 | $4.71B | -$311M | — | 45.7% | 2.0% | 126 | 尚无授权文本 |
| BJDX Bluejay Diagnostics, Inc. | 2026-03-31 | 3/3 | — | -$1.92M | -$1.61M | — | — | 82 | 尚无授权文本 |
| CDXS CODEXIS, INC. | 2026-03-31 | 3/3 | $15.25M | -$8.7M | -$13.33M | 86.5% | -52.7% | 90 | 尚无授权文本 |
| CLDX Celldex Therapeutics, Inc. | 2026-03-31 | 3/3 | $15,000 | -$78.69M | -$67.23M | — | -562900.0% | 71 | 尚无授权文本 |
| CODX Co-Diagnostics, Inc. | 2026-03-31 | 3/3 | $145,954 | -$9.14M | -$7.99M | -32.8% | -6309.1% | 79 | 尚无授权文本 |
| DXC DXC Technology Co | 2026-03-31 | 3/3 | $12.64B | $18M | $1.04B | — | 7.7% | 83 | 尚无授权文本 |
| DXPE DXP ENTERPRISES INC | 2026-03-31 | 3/3 | $521.66M | $19.98M | $26.28M | 32.3% | 8.1% | 83 | 尚无授权文本 |
| GRDX GridAI Technologies Corp. | 2026-03-31 | 3/3 | $38,208 | -$3.44M | — | -1606.3% | -9460.1% | 149 | 尚无授权文本 |
| IDXX IDEXX LABORATORIES INC /DE | 2026-03-31 | 3/3 | $1.14B | $278.45M | $234.26M | 63.4% | 31.8% | 74 | 尚无授权文本 |
| IMDX Insight Molecular Diagnostics Inc. | 2026-03-31 | 3/3 | $32,000 | -$4.29M | -$8.25M | 46.9% | -13790.6% | 124 | 尚无授权文本 |
| SNDX Syndax Pharmaceuticals Inc | 2026-03-31 | 3/3 | $64.86M | -$42.67M | — | — | -52.7% | 91 | 尚无授权文本 |
| TMDX TransMedics Group, Inc. | 2026-03-31 | 3/3 | $173.93M | $7.32M | -$12.12M | 58.2% | 7.6% | 89 | 尚无授权文本 |
| WGS GeneDx Holdings Corp. | 2026-03-31 | 3/3 | $102.25M | -$63.32M | -$38.86M | 66.7% | -56.2% | 87 | 尚无授权文本 |
| MDXH MDxHealth SA | 2025-12-31 | 2/3 | — | -$33.52M | — | — | — | 83 | 尚无授权文本 |
| DXST Decent Holding Inc. | 2025-10-31 | 3/3 | $12.95M | -$322,202 | -$3.46M | 26.2% | -1.1% | 16 | 尚无授权文本 |
| ADXN Addex Therapeutics Ltd. | 2025-06-30 | 2/3 | — | -$1.84M | — | — | — | 119 | 尚无授权文本 |
| DXF Eason Technology Ltd | 2025-06-30 | 2/3 | — | -$4.93M | — | — | — | 53 | 尚无授权文本 |
| RADX Radiopharm Theranostics Ltd | 2025-06-30 | 2/3 | — | -$38.34M | — | — | — | 74 | 尚无授权文本 |
| AADX Applied Aerospace & Defense, Inc. | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| ADX ADAMS DIVERSIFIED EQUITY FUND, INC. | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| DXR DAXOR CORP | — | 0/3 | — | — | — | — | — | 22 | 尚无授权文本 |
| DXYZ Destiny Tech100 Inc. | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |
| FDXF FedEx Freight Holding Company, Inc. | — | 0/3 | — | — | — | — | — | 5 | 尚无授权文本 |
| PDX PIMCO Dynamic Income Strategy Fund | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |